| Literature DB >> 29969912 |
Najib Isse Dirie1, Qing Wang1, Shaogang Wang1.
Abstract
BACKGROUND: Laparoscopy is widely used in the urological field. This systematic review and a meta-analysis were conducted to assess the clinical and surgical efficacy of the three-dimensional (3D) laparoscopic system in comparison with two-dimensional (2D) laparoscopy for treatment of different urological conditions.Entities:
Keywords: comparison; meta-analysis; three-dimensional laparoscopy; two-dimensional laparoscopy; urological surgeries
Mesh:
Year: 2018 PMID: 29969912 PMCID: PMC6156697 DOI: 10.1089/end.2018.0411
Source DB: PubMed Journal: J Endourol ISSN: 0892-7790 Impact factor: 2.942
Characteristics of All Published Studies Comparing Two-Dimensional and Three-Dimensional Laparoscopic Urological Surgeries
| p | p | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agrusa et al.[ | Retrospective | Adrenalectomy | 26 | 13 | 54.3 | 55.8 | 17/9 | 8/5 | 120 | 110 | NA | NA | NA | NA | KARL STORZ 3D System | 8 |
| Chen[ | Randomized | Ureterolithotomy | 20 | 25 | 45.8 | 41.56 | 10/10 | 14/11 | 64.13 | 81.1 | NA | NA | NA | Viking 3D HD vision system | 8 | |
| Tang et al.[ | Retrospective | Cystectomy | 24 | 18 | 64.2 | 63.3 | 20/4 | 15/3 | 150.6 | 133.1 | 217.5 | 211.7 | 0.829 | Viking 3D HD system | 8 | |
| Patankar and Padasalagi[ | Randomized | SN | 26 | 28 | NA | NA | NA | NA | 139.5 | 96 | <0.012 | 240 | 181.4 | Viking 3D HD vision system | 8 | |
| Patankar and Padasalagi[ | Randomized | RN | 8 | 6 | NA | NA | NA | NA | 166.8 | 143.3 | <0.416 | 340 | 290 | <0.641 | Viking 3D HD vision system | 8 |
| Patankar and Padasalagi[ | Randomized | Pyeloplasty | 19 | 21 | NA | NA | NA | NA | 157.6 | 121.1 | 95.2 | 67.14 | Viking 3D HD vision system | 8 | ||
| Xu et al.[ | Retrospective | Pyeloplasty | 15 | 16 | 31.0 | 30.0 | 7/8 | 9/7 | 124 | 106 | 57 | 54 | 0.244 | NA | 8 | |
| Kozlov et al.[ | Retrospective | Pyeloplasty | 12 | 15 | 61.50 | 66.25 | NA | NA | 78.75 | 61.31 | NA | NA | NA | 3D TIPCAM (KARL STORZ) | 8 | |
| Abou-Haidar et al.[ | Retrospective | Pyeloplasty | 19 | 8 | 8 | 7 | NA | NA | 265 | 217 | NA | NA | NA | 3D vision system (ConMed) | 8 | |
| Xu et al.[ | Retrospective | PN | 47 | 38 | 54.6 | 54.8 | 25/22 | 24/14 | 93.5 | 81.2 | 0.0001 | 68.5 | 55.5 | 0.069 | KARL STORZ 3D System | 8 |
| Ruan et al.[ | Randomized | PN | 45 | 45 | 58.7 | 60.4 | 22/23 | 24/21 | 92.2 | 97.5 | 0.22 | 105.5 | 159.3 | Viking 3D HD system | 8 | |
| Komatsuda et al.[ | Retrospective | PN | 20 | 11 | 57.3 | 53.0 | 18/2 | 9/2 | 175.2 | 157.8 | 0.348 | 22.8 | 37.3 | Olympus 3D LTV systems | 8 | |
| Tan et al.[ | Retrospective | PN | 81 | 53 | 53.9 | 51.1 | 58/23 | 36/17 | 217.0 | 193.4 | 0.015 | 168.9 | 160.9 | 0.727 | Olympus 3D LTV systems | 8 |
| Aykan et al.[ | Retrospective | Prostatectomy | 66 | 29 | 64.5 | 65 | — | — | 190 | 131 | 138 | 102 | Viking 3D HD vision System | 9 | ||
| Bove et al.[ | Retrospective | Prostatectomy | 43 | 43 | 60.1 | 63.9 | — | — | 241 | 90 | 532 | 383 | 0.11 | 3D-HD Viking camera | 8 | |
| Kinoshita et al.[ | Randomized | Prostatectomy | 57 | 59 | 65.9 | 66.5 | — | — | 148 | 150 | 0.98 | NA | NA | NA | Olympus 3D LTV systems | 9 |
| Xu et al.[ | Retrospective | Prostatectomy | 32 | 18 | 67.8 | 67.3 | — | — | 180.2 | 118.3 | 236.5 | 89.1 | KARL STORZ 3D System | 8 | ||
| Tang et al.[ | Retrospective | Prostatectomy | 36 | 36 | 66.03 | 65.14 | — | — | 218.1 | 167.7 | 177.8 | 86.1 | 3D-HD Viking camera | 8 | ||
| Wang and Pan[ | Retrospective | Prostatectomy | 34 | 38 | 61.9 | 64.2 | — | — | 175.7 | 162.7 | 211.8 | 191.1 | 3D-HD Viking camera | 8 | ||
Boldface indicates statistically significant values.
2D = two-dimensional; 3D = three-dimensional; M/F = male/female; SN = simple nephrectomy; RN = radical nephrectomy; PN = partial nephrectomy; NA = not available; — = not applicable; HD = high-definition; LTV = laparo-thoraco videoscope.
Meta-Analysis Summary (Two-Dimensional
| p | p | |||||||
|---|---|---|---|---|---|---|---|---|
| Partial nephrectomy | ||||||||
| Operative time (minutes) | 4 | 193/147 | 9.56 (−4.60 to 23.73) | 0.19 | 21.74 | 3 | 86 | 0.0001 |
| EBL (mL) | 4 | 193/147 | −12.76 (−50.56 to 25.04) | 0.51 | 30.79 | 3 | 90 | 0.0001 |
| Dissecting time (minutes) | 2 | 65/56 | 0.88 (−4.02 to 2.25) | 0.58 | 5.19 | 1 | 81 | 0.02 |
| Suturing time (mL) | 2 | 65/56 | 2.17 (−2.19 to 7.16) | 0.28 | 20.30 | 1 | 95 | <0.00001 |
| WIT (minutes) | 4 | 193/147 | 2.85 (1.85–3.86) | 1.45 | 3 | 0 | 0.070 | |
| Pyeloplasty | ||||||||
| Operative time (minutes) | 3 | 53/45 | 20.77 (−24.82 to 66.35) | 0.37 | 22.82 | 2 | 91 | <0.0001 |
| EBL (mL) | 2 | 34/37 | 10.88 (−19.44 to 41.20) | 0.48 | 5.95 | 1 | 83 | 0.01 |
| Prostatectomy | ||||||||
| Operative time (minutes) | 6 | 268/223 | 42.85 (17.44–68.27) | 108.0 | 5 | 95 | <0.0001 | |
| EBL (mL) | 5 | 211/164 | 78.38 (31.59–125.1) | 74.65 | 4 | 95 | <0.0001 | |
| UVA (minutes) | 4 | 206/169 | 18.23 (−1.78 to 38.24) | 0.07 | 574.3 | 3 | 99 | <0.0001 |
| Hospital stay (days) | 2 | 68/54 | 2.94 (−2.20 to 8.90) | 0.26 | 5.25 | 1 | 98 | 0.02 |
| PSM | 4 | 177/126 | OR: 1.57 (0.68–3.64) | 0.29 | 0.26 | 2 | 0 | 0.88 |
| Continence recovery | 4 | 177/145 | OR: 0.40 (0.21–0.78) | 0.13 | 3 | 27 | 0.25 | |
Boldface indicates statistically significant values.
WIT = warm ischemia time; UVA = urethrovesical anastomosis; MD = mean difference; OR = odds ratio; CI = confidence interval; EBL = estimated blood loss; PSM = positive surgical margin.

Flow chart of study search, inclusions, and exclusions.

Forest plot and meta-analysis results of partial nephrectomy (2D vs 3D laparoscopy). 2D = two-dimensional; 3D = three-dimensional; M-H = Mantel–Haenszel; CI = confidence interval.

Forest plot and meta-analysis results of the pyeloplasty procedure (2D vs 3D laparoscopy).

Forest plot and meta-analysis results of radical prostatectomy (2D vs 3D laparoscopy).

Forest plot and meta-analysis results of PSMs and continence recovery after radical prostatectomy (2D vs 3D laparoscopy). PSMs = positive surgical margins.